Anti-inflammatory effects of propofol during cardiopulmonary bypass: A pilot study

INTRODUCTION: Propofol has been suggested as a useful adjunct to cardiopulmonary bypass (CPB) because of its potential protective effect on the heart mediated by a decrease in ischemia-reperfusion injury and inflammation at clinically relevant concentrations. In view of these potentially protective...

Descripción completa

Detalles Bibliográficos
Autores principales: Samir, A., Gandreti, N., Madhere, M., Khan, A., Brown, M., Loomba, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881689/
https://www.ncbi.nlm.nih.gov/pubmed/26440235
http://dx.doi.org/10.4103/0971-9784.166451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881689/
https://www.ncbi.nlm.nih.gov/pubmed/26440235
http://dx.doi.org/10.4103/0971-9784.166451

Ejemplares similares